98 related articles for article (PubMed ID: 28269751)
61. Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer.
Hilska M; Roberts PJ; Collan YU; Laine VJ; Kössi J; Hirsimäki P; Rahkonen O; Laato M
Int J Cancer; 2007 Aug; 121(4):714-23. PubMed ID: 17455256
[TBL] [Abstract][Full Text] [Related]
62. Elevated expression of Thoc1 is associated with aggressive phenotype and poor prognosis in colorectal cancer.
Liu C; Yue B; Yuan C; Zhao S; Fang C; Yu Y; Yan D
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):53-8. PubMed ID: 26545775
[TBL] [Abstract][Full Text] [Related]
63. The Expression and Significance of CXCR5 and MMP-13 in Colorectal Cancer.
Yan Q; Yuan Y; Yankui L; Jingjie F; Linfang J; Yong P; Dong H; Xiaowei Q
Cell Biochem Biophys; 2015 Sep; 73(1):253-9. PubMed ID: 25726157
[TBL] [Abstract][Full Text] [Related]
64. The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer.
Hettiaratchi A; Hawkins NJ; McKenzie G; Ward RL; Hunt JE; Wakefield D; Di Girolamo N
Br J Cancer; 2007 Mar; 96(5):783-92. PubMed ID: 17311017
[TBL] [Abstract][Full Text] [Related]
65. Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer.
Hibino Y; Sakamoto N; Naito Y; Goto K; Oo HZ; Sentani K; Hinoi T; Ohdan H; Oue N; Yasui W
Pathobiology; 2015; 82(5):233-41. PubMed ID: 26389729
[TBL] [Abstract][Full Text] [Related]
66. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
Schwandner O; Schlamp A; Broll R; Bruch HP
Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992
[TBL] [Abstract][Full Text] [Related]
67. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
68. Expression of Immune-Related and Inflammatory Markers and Their Prognostic Impact in Colorectal Cancer Patients.
An S; Kim SK; Kwon HY; Kim CS; Bang HJ; Do H; Kim B; Kim K; Kim Y
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511338
[TBL] [Abstract][Full Text] [Related]
69. High expression level of TMPRSS4 predicts adverse outcomes of colorectal cancer patients.
Huang A; Zhou H; Zhao H; Quan Y; Feng B; Zheng M
Med Oncol; 2013 Dec; 30(4):712. PubMed ID: 24072509
[TBL] [Abstract][Full Text] [Related]
70. CHIP-mediated ubiquitination of Galectin-1 predicts colorectal cancer prognosis.
Wang W; Zhou Z; Xiang L; Lv M; Ni T; Deng J; Wang H; Masatara S; Zhou Y; Liu Y
Int J Biol Sci; 2020; 16(4):719-729. PubMed ID: 32025218
[TBL] [Abstract][Full Text] [Related]
71. ROCK I Has More Accurate Prognostic Value than MET in Predicting Patient Survival in Colorectal Cancer.
Li J; Bharadwaj SS; Guzman G; Vishnubhotla R; Glover SC
Anticancer Res; 2015 Jun; 35(6):3267-73. PubMed ID: 26026086
[TBL] [Abstract][Full Text] [Related]
72. Tumor necrosis factor-α-inducible protein 8-like protein 3 (TIPE3): a novel prognostic factor in colorectal cancer.
Xu Y; Zhu Y; Xia H; Wang Y; Li L; Wan H; Zhang S; Xu A; Wang L; Gong J; Zhang P
BMC Cancer; 2023 Feb; 23(1):131. PubMed ID: 36755222
[TBL] [Abstract][Full Text] [Related]
73. Stability of matrix metalloproteinase-9 as biological marker in colorectal cancer.
Jonsson A; Hjalmarsson C; Falk P; Ivarsson ML
Med Oncol; 2018 Mar; 35(4):50. PubMed ID: 29520667
[TBL] [Abstract][Full Text] [Related]
74. Prognostic value of tumor progression-related gene expression in colorectal cancer patients.
Uhlmann ME; Georgieva M; Sill M; Linnemann U; Berger MR
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1631-40. PubMed ID: 22614156
[TBL] [Abstract][Full Text] [Related]
75. Investigation of cullin-3 gene expression changes in people with colorectal cancer and polyps in China.
Wei X; Zhao X; Zhao X; Yang X
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):29-33. PubMed ID: 38279499
[TBL] [Abstract][Full Text] [Related]
76. Relationship between metalloproteinase-9 (MMP-9) expression and clinicopathology in colorectal cancer: a cross-sectional study.
Mudatsir ; Labeda I; Uwuratuw JA; Hendarto J; Warsinggih ; Lusikooy RE; Mappincara ; Sampetoding S; Kusuma MI; Syarifuddin E; Arsyad A; Faruk M
Ann Med Surg (Lond); 2023 Sep; 85(9):4277-4282. PubMed ID: 37663709
[TBL] [Abstract][Full Text] [Related]
77. Stage-Dependent Levels of Brain-Derived Neurotrophic Factor and Matrix Metalloproteinase 9 in the Prognosis of Colorectal Cancer.
Večurkovská I; Mašlanková J; Tomečková V; Kaťuchová J; Kisková T; Fröhlichová L; Mareková M; Stupák M
Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509480
[TBL] [Abstract][Full Text] [Related]
78. Erratum for Liu et al., "Increasing the Unneddylated Cullin1 Portion Rescues the
Liu Q; Zhou Y; Tang R; Wang X; Hu Q; Wang Y; He Q
Mol Cell Biol; 2018 Feb; 38(4):. PubMed ID: 29378896
[No Abstract] [Full Text] [Related]
79. Combined Radiochemotherapy: Metalloproteinases Revisited.
Waller V; Pruschy M
Front Oncol; 2021; 11():676583. PubMed ID: 34055644
[TBL] [Abstract][Full Text] [Related]
80. ETV4 plays a role on the primary events during the adenoma-adenocarcinoma progression in colorectal cancer.
Fonseca AS; Ramão A; Bürger MC; de Souza JES; Zanette DL; de Molfetta GA; de Araújo LF; de Barros E Lima Bueno R; Aguiar GM; Plaça JR; Alves CP; Dos Santos ARD; Vidal DO; Silva GEB; Panepucci RA; Peria FM; Feres O; da Rocha JJR; Zago MA; Silva WA
BMC Cancer; 2021 Mar; 21(1):207. PubMed ID: 33648461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
